Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

被引:254
作者
Briles, DE
Ades, E
Paton, JC
Sampson, JS
Carlone, GM
Huebner, RC
Virolainen, A
Swiatlo, E
Hollingshead, SK
机构
[1] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
[4] Womens & Childrens Hosp, Mol Microbiol Unit, Adelaide, SA, Australia
[5] Pasteur Merieux Connaught, Swiftwater, PA USA
[6] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland
[7] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA
关键词
D O I
10.1128/IAI.68.2.796-800.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acquisition of pneumococci is generally from carriers rather than from infected individuals. Therefore, to induce herd immunity against Streptococcus pneumoniae it will be necessary to elicit protection against carriage. Capsular polysaccharide-protein conjugates, PspA, and PsaA are known to elicit some protection against nasopharyngeal carriage of pneumococci but do not always completely eliminate carriage. In this study, we observed that PsaA elicited better protection than did PspA against carriage. Pneumolysin elicited no protection against carriage. Immunization with a mixture of PsaA and PspA elicited the best protection against carriage. These results indicate that PspA and PsaA may be useful for the elicitation of herd immunity in humans. As PspA and pneumolysin are known to elicit immunity to bacteremia and pneumonia, their inclusion in a mucosal vaccine may enable such a vaccine to prevent invasive disease as well as carriage.
引用
收藏
页码:796 / 800
页数:5
相关论文
共 42 条
[1]  
ABEYTA M, 1999, THESIS U ALABAMA BIR
[2]   Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia [J].
Alexander, JE ;
Berry, AM ;
Paton, JC ;
Rubins, JB ;
Andrew, PW ;
Mitchell, TJ .
MICROBIAL PATHOGENESIS, 1998, 24 (03) :167-174
[3]   IMMUNIZATION OF MICE WITH PNEUMOLYSIN TOROID CONFERS A SIGNIFICANT DEGREE OF PROTECTION AGAINST AT LEAST 9 SEROTYPES OF STREPTOCOCCUS-PNEUMONIAE [J].
ALEXANDER, JE ;
LOCK, RA ;
PEETERS, CCAM ;
POOLMAN, JT ;
ANDREW, PW ;
MITCHELL, TJ ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1994, 62 (12) :5683-5688
[4]   Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production [J].
Benton, KA ;
Paton, JC ;
Briles, DE .
INFECTION AND IMMUNITY, 1997, 65 (04) :1237-1244
[5]   The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model [J].
Benton, KA ;
Paton, JC ;
Briles, DE .
MICROBIAL PATHOGENESIS, 1997, 23 (04) :201-209
[6]   Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae [J].
Berry, AM ;
Paton, JC .
INFECTION AND IMMUNITY, 1996, 64 (12) :5255-5262
[7]   Systemic and mucosal protective immunity to pneumococcal surface protein A [J].
Briles, DE ;
Tart, RC ;
Wu, HY ;
Ralph, BA ;
Russell, MW ;
McDaniel, LS .
MICROBIAL PATHOGENESIS AND IMMUNE RESPONSE II, 1996, 797 :118-126
[8]   PspA and PspC: Their potential for use as pneumococcal vaccines [J].
Briles, DE ;
Hollingshead, SK ;
Swiatlo, E ;
Brooks-Walter, A ;
Szalai, A ;
Virolainen, A ;
McDaniel, LS ;
Benton, KA ;
White, P ;
Prellner, K ;
Hermansson, A ;
Aerts, PC ;
Van Dijk, H ;
Crain, MJ .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (04) :401-408
[9]   PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice [J].
Briles, DE ;
King, JD ;
Gray, MA ;
McDaniel, LS ;
Swiatlo, E ;
Benton, KA .
VACCINE, 1996, 14 (09) :858-867
[10]  
BRILES DE, 1999, MOL BIOL PNEUMOCOCCI